Abstract
Botulinum toxin (BoNT), a potent neurotoxin that reversibly blocks presynaptic acetylcholine release, has been used successfully to treat sleep bruxism (SB) and chronic migraine (CM). However, studies investigating injection protocols such as drug dosage and injection site in the temporal muscle (TM) have rarely been reviewed. Therefore, recent studies involving the application of BoNT to the TM in patients with SB and CM was reviewed in this study.
| Original language | English |
|---|---|
| Pages (from-to) | 46-49 |
| Number of pages | 4 |
| Journal | Sleep Medicine Research |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2022 |
Bibliographical note
Funding Information:This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (Project Number: KMDF_ PR_20200901_0109, 1711138194).
Publisher Copyright:
© 2022. The Korean Society of Sleep Medicine. All Rights Reserved.
All Science Journal Classification (ASJC) codes
- Pulmonary and Respiratory Medicine
- Neurology
- Clinical Neurology
- Psychiatry and Mental health
- Physiology (medical)
